Postpartum depressive symptoms linked to higher infant mortality
In 415,000 New Jersey births, infants of mothers who screened positive for depression died before age one at more than three times the rate, an association steady across race, income and preterm birth.
| Group | Value (per 1,000 births) |
|---|---|
| Mother screened positive | 7.2 |
| Mother screened negative | 2 |
Perinatal depression is the most common complication of pregnancy, yet its consequences for the baby's survival have rarely been studied directly in the United States. A cohort study in JAMA Network Open, published 2 September, links maternal depressive symptoms measured after birth to a markedly higher risk of the infant dying in its first year [s1].
The study
The analysis used New Jersey birth records from 2016 to 2020 linked to death records through 2021, in a state that mandates screening for depressive symptoms in the immediate postpartum period — which is what makes the study possible at scale [s1]. It covered singleton infants, with maternal depressive symptoms defined as a score of 10 or higher on the Edinburgh Postnatal Depression Scale, the standard 10-item screening tool developed in 1987 [s1][s2].
Among 414,890 infants with complete data, 906 (0.2%) died before their first birthday [s1]. The mothers had a mean age of 30.5 years; 63.0% were born in the US, 60.0% were privately insured, and 70.6% had completed high school or college [s1].
The finding
The infant mortality rate was 7.2 per 1,000 births among infants whose mothers screened positive for depressive symptoms, against 2.0 per 1,000 among those whose mothers did not [s1]. After adjustment for measured covariates, the relative risk of death within 364 days of birth was 2.89 (95% CI, 2.36–3.54) for infants of mothers with depressive symptoms [s1].
What gives the association weight is its consistency. The elevated risk held across maternal race and ethnicity, educational level and insurance status, and across preterm and term births [s1]. When an association persists across so many strata, it is less likely to be an artefact of a single confounding factor concentrated in one group.
What it does not establish
The study cannot show that depression causes infant deaths, and the mechanism is almost certainly not direct. Depressive symptoms may be a marker for a cluster of harder-to-measure circumstances — material hardship, reduced access to care, co-occurring illness, less support — that themselves raise an infant's risk, and the screen captures symptoms at one point rather than a diagnosis or its treatment [s1]. Even adjusted models cannot rule out such residual confounding, and a screening tool like the EPDS identifies risk of depression, not a confirmed clinical disorder [s2]. The data also come from a single state with a screening mandate, so the population may not represent places where postpartum screening is patchier [s1].
The absolute figures are worth holding steady against alarm: the great majority of infants in both groups — 99.8% overall — survived their first year, and the elevated rate, though real, still describes a small minority of pregnancies [s1].
It is also worth being precise about what the exposure captures. The Edinburgh Postnatal Depression Scale was designed in 1987 as a brief self-report screen to flag mothers who may have depression, on the understanding that a positive screen is a prompt for clinical assessment, not a diagnosis in itself [s2]. A threshold of 10 or higher is a widely used cut-off, but it inevitably includes some women with transient distress and misses others, so the "depressive symptoms" group in this study is a screened population rather than a treated clinical cohort [s1][s2]. The study also examined whether the association varied across the leading causes of infant death, part of an effort to understand whether any single pathway explains the excess — but an observational cohort can map where the risk concentrates without establishing why [s1].
Why it matters anyway
New Jersey's screening mandate is what turned an under-studied question into an answerable one, and that is part of the story: routine postpartum screening does not only identify mothers who might benefit from treatment, it generates the data to see associations like this at all [s1]. Whether identifying and treating perinatal depression reduces infant mortality is the crucial next question — and it is one this observational study cannot answer. It establishes a strong, consistent association and a case for attention, not a demonstrated intervention.
If you or someone you know is struggling after a birth, this is a reason to reach out to a clinician; it is not a verdict about any individual pregnancy.
This article is informational and does not constitute medical advice.
Sources
- [s1] Perinatal Depression and Infant Mortality. JAMA Network Open, 2 September 2026. https://doi.org/10.1001/jamanetworkopen.2026.31364
- [s2] Detection of Postnatal Depression: Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 1987. https://doi.org/10.1192/bjp.150.6.782
Sources
- Perinatal Depression and Infant Mortality — JAMA Network Open , September 2, 2026
- Detection of Postnatal Depression: Development of the 10-item Edinburgh Postnatal Depression Scale — British Journal of Psychiatry , August 12, 2008
More on
Screen use explained at most 0.4% of the variation in adolescent well-being
Two large re-analyses of the same public datasets found the association is real, negative and very small. A third review found the association is not even consistent between the Global North and South.
Most kinds of therapy for depression worked. Almost none outperformed another.
A network meta-analysis of 331 trials and 34,285 adults found no significant differences between the main psychotherapies, with one exception. In children and adolescents the picture is narrower.
Therapy and antidepressants performed equally. Together they beat either alone.
A network meta-analysis of 101 trials and 11,910 patients found no significant difference between psychotherapy and medication for adult depression — and a consistent advantage for combining them.
Measurement-based care works in trials. Twenty-four years on, it still rarely lands
A systematic review found only 16 usable studies of how to implement routine symptom monitoring in adult mental health services. A 4,778-patient clinic dataset shows what it looks like when it does.